Literature DB >> 2383160

Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.

L Bookstein1, S S Gidding, M Donovan, F A Smith.   

Abstract

The National Cholesterol Education Program has recently published guidelines for the assessment of cardiovascular risk and goals for laboratory accuracy. To test the impact of biologic and analytic variability on the ability of a single lipid measurement to assess risk accurately, lipids were measured on three occasions in 51 volunteers. Notable day-to-day variability of total cholesterol (5%), triglyceride (20%), high-density lipoprotein cholesterol (10%), and calculated low-density lipoprotein cholesterol (8%) levels was found. Analytic variability contributed significantly to total variability of high-density lipoprotein cholesterol levels and calculated low-density lipoprotein cholesterol levels. Confidence intervals constructed around National Cholesterol Education Program cutoff points suggested that classification was reliable from a single measurement if total cholesterol value was below 4.78 (less than 185 mg/dL), between 5.56 and 5.81 (215 and 225 mg/dL), or above 6.59 mmol/L (greater than 225 mg/dL). Low-density lipoprotein cholesterol value classification from a single measurement was only accurate at below 3.00 (greater than 116 mg/dL) or above 4.50 mmol/L (greater than 174 mg/dL). This study documents significant day-to-day variability of serum lipids and suggests that patients near the National Cholesterol Education Program cutoff points may require repeated measurements to assign risk accurately.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383160

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

1.  A short-term religious "fast" from animal products has a minimal impact on cardiometabolic health biomarkers irrespective of concurrent shifts in distinct plant-based food groups.

Authors:  Hilary J Bethancourt; Mario Kratz; Kathleen O'Connor
Journal:  Am J Clin Nutr       Date:  2019-09-01       Impact factor: 7.045

2.  Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy.

Authors:  Boris Guiu; Elodie Crevisy-Girod; Christine Binquet; Laurence Duvillard; David Masson; Côme Lepage; Samia Hamza; Denis Krausé; Bruno Verges; Anne Minello; Jean-Pierre Cercueil; Patrick Hillon; Jean-Michel Petit
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

Review 3.  Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

4.  Intraindividual variation in lipid and lipoprotein levels.

Authors:  S L Shumak; N R Campbell
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

Review 5.  Short term effects of exercise on plasma lipids and lipoproteins in humans.

Authors:  N P Pronk
Journal:  Sports Med       Date:  1993-12       Impact factor: 11.136

6.  Colloquium papers: Natural selection in a contemporary human population.

Authors:  Sean G Byars; Douglas Ewbank; Diddahally R Govindaraju; Stephen C Stearns
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

7.  Does lowering of cholesterol levels influence functional properties of large arteries?

Authors:  M Kool; F Lustermans; H Kragten; H Struijker Boudier; A Hoeks; R Reneman; H Rila; I Hoogendam; L Van Bortel
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Invited commentary: Maternal plasma polybrominated diphenyl ethers and thyroid hormones--challenges and opportunities.

Authors:  Jonathan Chevrier
Journal:  Am J Epidemiol       Date:  2013-08-07       Impact factor: 4.897

9.  Is hyperlipidaemia a contributing factor to algodystrophy (reflex sympathetic dystrophy)?

Authors:  F Eulry; X Chevalier; P Crozes; M Prudat; D Lechevalier; B Larget-Piet
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

10.  Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals.

Authors:  MyPhuong T Le; Maximilian T Lobmeyer; Marcus Campbell; Jing Cheng; Zhiying Wang; Stephen T Turner; Arlene B Chapman; Eric Boerwinkle; John G Gums; Yan Gong; Richard J Johnson; Julie A Johnson
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.